254 related articles for article (PubMed ID: 25502178)
1. A modified murine model of systemic sclerosis: bleomycin given by pump infusion induced skin and pulmonary inflammation and fibrosis.
Liang M; Lv J; Zou L; Yang W; Xiong Y; Chen X; Guan M; He R; Zou H
Lab Invest; 2015 Mar; 95(3):342-50. PubMed ID: 25502178
[TBL] [Abstract][Full Text] [Related]
2. Optimization of a murine and human tissue model to recapitulate dermal and pulmonary features of systemic sclerosis.
Watanabe T; Nishimoto T; Mlakar L; Heywood J; Malaab M; Hoffman S; Feghali-Bostwick C
PLoS One; 2017; 12(6):e0179917. PubMed ID: 28651005
[TBL] [Abstract][Full Text] [Related]
3. A mouse model of progressive lung fibrosis with cutaneous involvement induced by a combination of oropharyngeal and osmotic minipump bleomycin delivery.
Grandi A; Ferrini E; Zoboli M; Buseghin D; Pennati F; Khalajzeyqami Z; Ciccimarra R; Villetti G; Stellari FF
Am J Physiol Lung Cell Mol Physiol; 2024 Jun; 326(6):L736-L753. PubMed ID: 38651940
[TBL] [Abstract][Full Text] [Related]
4. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
[TBL] [Abstract][Full Text] [Related]
5. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
[TBL] [Abstract][Full Text] [Related]
6. High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis.
Harrison JH; Lazo JS
J Pharmacol Exp Ther; 1987 Dec; 243(3):1185-94. PubMed ID: 2447265
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of lung inflammation and fibrosis in CD69-deficient mice after intratracheal bleomycin.
Yamauchi K; Kasuya Y; Kuroda F; Tanaka K; Tsuyusaki J; Ishizaki S; Matsunaga H; Iwamura C; Nakayama T; Tatsumi K
Respir Res; 2011 Oct; 12(1):131. PubMed ID: 21970554
[TBL] [Abstract][Full Text] [Related]
8. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice.
Saito F; Tasaka S; Inoue K; Miyamoto K; Nakano Y; Ogawa Y; Yamada W; Shiraishi Y; Hasegawa N; Fujishima S; Takano H; Ishizaka A
Am J Respir Cell Mol Biol; 2008 May; 38(5):566-71. PubMed ID: 18096870
[TBL] [Abstract][Full Text] [Related]
9. Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease.
Lee R; Reese C; Bonner M; Tourkina E; Hajdu Z; Riemer EC; Silver RM; Visconti RP; Hoffman S
Am J Physiol Lung Cell Mol Physiol; 2014 Apr; 306(8):L736-48. PubMed ID: 24583879
[TBL] [Abstract][Full Text] [Related]
10. Histopathological Correlations between Mediastinal Fat-Associated Lymphoid Clusters and the Development of Lung Inflammation and Fibrosis following Bleomycin Administration in Mice.
Elewa YHA; Ichii O; Takada K; Nakamura T; Masum MA; Kon Y
Front Immunol; 2018; 9():271. PubMed ID: 29497425
[TBL] [Abstract][Full Text] [Related]
11. The Fibrosis and Immunological Features of Hypochlorous Acid Induced Mouse Model of Systemic Sclerosis.
Meng M; Tan J; Chen W; Du Q; Xie B; Wang N; Zhu H; Wang K
Front Immunol; 2019; 10():1861. PubMed ID: 31481954
[TBL] [Abstract][Full Text] [Related]
12. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis.
Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL
Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424
[TBL] [Abstract][Full Text] [Related]
13. Mouse model of dermal fibrosis induced by one-time injection of bleomycin-poly(L-lactic acid) microspheres.
Shibusawa Y; Negishi I; Tabata Y; Ishikawa O
Rheumatology (Oxford); 2008 Apr; 47(4):454-7. PubMed ID: 18316335
[TBL] [Abstract][Full Text] [Related]
14. FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice.
Yara S; Kawakami K; Kudeken N; Tohyama M; Teruya K; Chinen T; Awaya A; Saito A
Clin Exp Immunol; 2001 Apr; 124(1):77-85. PubMed ID: 11359445
[TBL] [Abstract][Full Text] [Related]
15. Knockout of endothelin type B receptor signaling attenuates bleomycin-induced skin sclerosis in mice.
Akashi K; Saegusa J; Sendo S; Nishimura K; Okano T; Yagi K; Yanagisawa M; Emoto N; Morinobu A
Arthritis Res Ther; 2016 May; 18(1):113. PubMed ID: 27209208
[TBL] [Abstract][Full Text] [Related]
16. Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis.
Huaux F; Liu T; McGarry B; Ullenbruch M; Xing Z; Phan SH
J Immunol; 2003 Nov; 171(10):5470-81. PubMed ID: 14607953
[TBL] [Abstract][Full Text] [Related]
17. The Role of TLR7 and TLR9 in the Pathogenesis of Systemic Sclerosis.
Wang C; Oishi K; Kobayashi T; Fujii K; Horii M; Fushida N; Kitano T; Maeda S; Ikawa Y; Komuro A; Hamaguchi Y; Matsushita T
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892317
[TBL] [Abstract][Full Text] [Related]
18. alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: melanocortin peptides as a novel treatment strategy for scleroderma?
Kokot A; Sindrilaru A; Schiller M; Sunderkötter C; Kerkhoff C; Eckes B; Scharffetter-Kochanek K; Luger TA; Böhm M
Arthritis Rheum; 2009 Feb; 60(2):592-603. PubMed ID: 19180474
[TBL] [Abstract][Full Text] [Related]
19. SSC-ILD mouse model induced by osmotic minipump delivered bleomycin: effect of Nintedanib.
Ravanetti F; Ferrini E; Ragionieri L; Khalajzeyqami Z; Nicastro M; Ridwan Y; Kleinjan A; Villetti G; Grandi A; Stellari FF
Sci Rep; 2021 Sep; 11(1):18513. PubMed ID: 34531421
[TBL] [Abstract][Full Text] [Related]
20. Modeling pulmonary fibrosis through bleomycin delivered by osmotic minipump: a new histomorphometric method of evaluation.
Ravanetti F; Ragionieri L; Ciccimarra R; Ruscitti F; Pompilio D; Gazza F; Villetti G; Cacchioli A; Stellari FF
Am J Physiol Lung Cell Mol Physiol; 2020 Feb; 318(2):L376-L385. PubMed ID: 31851533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
